Defined Cell Culture Highlights:

Stem Cell Metabolism, Scalable T Cells & Cell State Engineering

September 8-14, 2026

New studies in intestinal stem cells, pluripotent stem cell-derived immune cells, early embryonic states, cardiac reprogramming, and genome editing highlighted the importance of controlling both the culture environment and the starting cell state. Metabolism, matrix format, developmental timing, and cellular activation history all influenced whether cells retained stemness, differentiated efficiently, or responded predictably to engineering.

Mitochondrial metabolism restores function in aging intestinal stem cells

A Communications Biology study published September 10 examined why intestinal stem cells lose regenerative capacity with age.

Using patient-derived human duodenal enteroids and Lgr5 reporter mice, the researchers found that aging altered how intestinal stem cells use metabolic fuels. Older cells shifted away from fatty acids and toward glucose-derived pyruvate, but much of that pyruvate was directed toward cytosolic glycolysis rather than mitochondrial oxidation.

Increasing pyruvate dehydrogenase activity redirected glucose-derived carbon into the mitochondrial tricarboxylic acid (TCA) cycle. This increased oxygen consumption and mitochondrial ATP production while restoring features associated with intestinal stem cell identity. Regulation of PDK4, which inhibits pyruvate dehydrogenase, emerged as an important control point.

This study illustrates why media development should consider how nutrients are processed, not simply whether they are present. Two formulations with similar glucose, lipid, and amino acid concentrations can produce different outcomes if they drive different patterns of mitochondrial metabolism.

For organoid models of aging, disease, or tissue regeneration, metabolic state may therefore be an important quality attribute alongside morphology, marker expression, and organoid formation efficiency.

Read the study in its current form here. As of this posting, this article is subject to further edits before final release.

Suspended thymic organoids support scalable T-cell production

A Stem Cell Reports study published online September 10 developed a suspension-based approach for producing T lymphocytes from human pluripotent stem cells.

Artificial thymic organoids typically combine hematopoietic progenitors with stromal cells engineered to provide signals such as DLL4. These systems can support T-cell differentiation, but conventional aggregate or Transwell formats are difficult to scale and standardize.

The researchers first developed a Matrigel-based artificial thymic organoid called Gel-ATO. They then transferred the system into rotating suspension culture, allowing the organoids to remain suspended while improving interaction between pluripotent stem cell-derived hematopoietic progenitors and DLL4-expressing stromal cells.

The resulting cells progressed through early lymphoid and CD4/CD8 double-positive stages. The system also generated antigen-specific T cells that could expand after activation and kill target cancer cells in vitro. Rotating suspension provides a potential route toward increasing production without relying on individually assembled organoids.

The current workflow is not fully defined or animal-free. It uses Matrigel, stromal feeder cells, and additional animal-derived culture components. Nevertheless, it demonstrates how organoid geometry, matrix composition, cell ratios, and fluid movement can be engineered together to make a complex differentiation process more scalable.

Replacing variable biological matrices and feeder-dependent signals with defined components could be an important next step toward consistent manufacturing of pluripotent stem cell-derived immune cells.

You can find the paper here.

A defined induction strategy recreates an early human embryonic state

A Nature Protocols paper published September 11 provided a detailed workflow for generating eight-cell (8C) embryo-like cells from human pluripotent stem cells.

The 8C stage is associated with major zygotic genome activation, when the embryonic genome begins directing development. Access to human embryos at this stage is limited, creating a need for experimentally tractable cell models.

The protocol uses a specially formulated induction medium containing selected small molecules and cytokines. Researchers can begin with naïve pluripotent stem cells and generate 8C-like cells through a five-day stepwise process, or start directly with primed pluripotent stem cells in a workflow taking approximately seven days.

The resulting cells display transcriptional and epigenetic features associated with human 8C embryos. The paper also describes methods for isolating and characterizing the induced population using reporters, immunofluorescence, and single-cell RNA sequencing.

This work illustrates how tightly timed media transitions can move pluripotent cells into transient developmental states that are rarely represented in routine culture. It also reinforces the importance of distinguishing between primed, naïve, and totipotent-like states when comparing PSC lines or interpreting differentiation results.

As stem cell models move closer to early development, media composition and timing become part of the experimental definition of the cell state, rather than background details of the protocol.

Read the protocol here.

Activated fibroblasts resist cardiac reprogramming

A Circulation study published September 8 investigated why cardiac fibroblasts become more difficult to reprogram after myocardial infarction.

Direct cardiac reprogramming aims to convert fibroblasts into induced cardiomyocytes. In principle, this could reduce scar formation while replacing some of the contractile cells lost after injury. In practice, reprogramming efficiency varies substantially depending on the fibroblast population and its biological state.

In this study, researchers found that fibroblasts activated after injury progressed into myofibroblasts with intrinsic barriers to cardiac conversion. These cells are responsible for producing the extracellular matrix that forms a fibrotic scar, but their activated identity also makes them less responsive to conventional cardiac reprogramming factors.

By identifying and addressing these barriers, the researchers increased conversion of injury-associated myofibroblasts toward cardiomyocyte-like cells and improved cardiac repair in experimental models.

The study illustrates a broader issue in cell differentiation and reprogramming. Cells classified under the same general name can respond very differently depending on age, activation state, metabolic history, matrix exposure, and inflammatory signaling.

For in vitro cardiac workflows, this means that differentiation efficiency alone may not be sufficient to compare conditions. Starting cell state, viable yield, structural maturity, metabolism, contractility, and electrophysiological function all need to be considered when evaluating a reprogramming or maturation system.

Read the study here.

Base editing exposes different DNA repair responses in early human development

A Nature study published September 9 compared how early human embryos respond to two different forms of genome editing.

Conventional CRISPR-Cas9 editing creates a double-strand DNA break. Adenine base editors can introduce specific nucleotide changes using a single-strand nick, potentially reducing the unpredictable repair events associated with double-strand breaks.

The researchers edited PCSK9 and HBG and found that early human embryos repaired single-strand damage more reliably than double-strand breaks. Delivery of the base editor as a protein was compatible with development to the blastocyst stage, and the researchers derived stem cell lines from edited six-day embryos for more detailed genetic analysis.

More than 100 single-cell samples were examined to evaluate less common editing outcomes. This level of analysis is important because a high average editing rate can conceal mosaicism, rare unintended changes, or differences between cells within the same embryo or culture.

The study was designed to investigate DNA repair in early development, not to establish a clinical embryo editing procedure. Important safety and ethical questions remain.

The findings are nevertheless relevant to engineered pluripotent stem cell workflows. Editing efficiency should be evaluated together with clonal composition, genomic integrity, cell viability, developmental competence, and stability during subsequent expansion. Deriving an apparently healthy edited line does not eliminate the need for detailed characterization.

You can find the paper here. As of this posting, this article is subject to further edits before final release.

The week’s takeaway

Intestinal stem cells demonstrated that directing nutrients into the correct metabolic pathway can restore regenerative features lost with age. Suspended thymic organoids showed how matrix format, cell ratios, and fluid movement can make pluripotent stem cell differentiation more scalable. 8C-like cells illustrated the precision with which timed media changes can produce transient developmental states.

Cardiac reprogramming and embryo base editing reinforced the importance of cellular history and heterogeneity. Starting cells that look similar may differ in activation state, repair capacity, or responsiveness, and population-level measurements can miss those differences.

Across these studies, reproducible cell culture depended on controlling more than the concentration of a few growth factors. Metabolism, matrix, timing, physical environment, starting-cell state, and analytical resolution all shaped the final biological outcome.

Whether you are developing a PSC, organoid, cell therapy, or disease modeling workflow, reducing variability starts with well-characterized media and supplements. Defined Bioscience provides animal-free solutions and custom media development. Explore our products or contact us to discuss your workflow.